Cargando…

Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon

A clinically reflective model of the human colon was used to investigate the effects of the broad-spectrum antibiotic omadacycline on the gut microbiome and the subsequent potential to induce simulated Clostridium difficile infection (CDI). Triple-stage chemostat gut models were inoculated with pool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moura, Ines B., Buckley, Anthony M., Ewin, Duncan, Shearman, Sharie, Clark, Emma, Wilcox, Mark H., Chilton, Caroline H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355569/ https://www.ncbi.nlm.nih.gov/pubmed/30455242 http://dx.doi.org/10.1128/AAC.01581-18

Ejemplares similares

Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo
por: Nale, Janet Y., et al.
Publicado: (2016)

In Vitro Activities of Omadacycline and Comparators against Anaerobic Bacteria
por: Stapert, Laure, et al.
Publicado: (2018)

Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
por: Garey, Kevin W., et al.
Publicado: (2022)

Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis
por: Karau, Melissa J., et al.
Publicado: (2022)

Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study
por: Freeman, Jane, et al.
Publicado: (2019)

Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota
por: Crowther, Grace S., et al.
Publicado: (2014)

In Vivo Assessment of SMT19969 in a Hamster Model of Clostridium difficile Infection
por: Weiss, William, et al.
Publicado: (2014)

The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection
por: Buckley, Anthony M, et al.
Publicado: (2021)

The Enterotoxicity of Clostridium difficile Toxins
por: Sun, Xingmin, et al.
Publicado: (2010)

Duodenitis‐Proximal Jejunitis in Horses After Experimental Administration of Clostridium difficile Toxins
por: Arroyo, L.G., et al.
Publicado: (2016)

In vitro models to study Clostridioides difficile infection: current systems and future advances
por: Ewin, Duncan, et al.
Publicado: (2023)

Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon
por: Moura, Ines B., et al.
Publicado: (2020)

Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B
por: Dhillon, Harvinder S., et al.
Publicado: (2016)

In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
por: Begum, Khurshida, et al.
Publicado: (2020)

Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study
por: Overcash, J. Scott, et al.
Publicado: (2019)

Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline
por: Bidell, Monique R., et al.
Publicado: (2021)

Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
por: Chilton, C. H., et al.
Publicado: (2016)

The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome
por: Davies, Kerrie A., et al.
Publicado: (2018)

A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models
por: Roberts, April K., et al.
Publicado: (2020)

Metal Ion Activation of Clostridium sordellii Lethal Toxin and Clostridium difficile Toxin B
por: Genth, Harald, et al.
Publicado: (2016)

Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)

Proteomic Analysis and Label-Free Quantification of the Large Clostridium difficile Toxins
por: Moura, Hercules, et al.
Publicado: (2013)

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
por: El Ghali, Amer, et al.
Publicado: (2023)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

661. In vitro Activity of Omadacycline and Comparator Antibiotics against Clostridioides difficile
por: Skinner, Andrew M, et al.
Publicado: (2022)

Binary Toxin and Death after Clostridium difficile Infection
por: Bacci, Sabrina, et al.
Publicado: (2011)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins
por: Chen, Shuyi, et al.
Publicado: (2015)

The Regulatory Networks That Control Clostridium difficile Toxin Synthesis
por: Martin-Verstraete, Isabelle, et al.
Publicado: (2016)

Structure of the full-length Clostridium difficile toxin B
por: Chen, Peng, et al.
Publicado: (2019)

Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models
por: Spencer, Janice, et al.
Publicado: (2014)

A Review of Mixed Strain Clostridium difficile Colonization and Infection
por: Dayananda, Pete, et al.
Publicado: (2019)

Role of cephalosporins in the era of Clostridium difficile infection
por: Wilcox, Mark H., et al.
Publicado: (2017)

Clostridium difficile toxin B induces autophagic cell death in colonocytes
por: Chan, Hung, et al.
Publicado: (2018)

EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin
por: Schnell, Leonie, et al.
Publicado: (2016)

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage
por: Eyre, David W., et al.
Publicado: (2019)

Clostridium difficile Infection Caused by Binary Toxin–Positive Strains
por: Hensgens, Marjolein P.M., et al.
Publicado: (2013)

Genes Encoding Toxin of Clostridium difficile in Children with and without Diarrhea
por: Merino, Victor R. C., et al.
Publicado: (2014)

Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling
por: Darkoh, Charles, et al.
Publicado: (2015)

Increased toxin expression in a Clostridium difficile mfd mutant
por: Willing, Stephanie E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_223qqn7mg2v1lns98aebdq8r8o